Pirkle Sean, Cook David J, Kaskovich Samuel, Bhattacharjee Sarah, Ho Alisha, Shi Lewis L, Lee Michael J
12246University of Chicago, Chicago, IL, USA.
Global Spine J. 2021 Mar;11(2):161-166. doi: 10.1177/2192568219896295. Epub 2019 Dec 26.
Retrospective, database review.
Examine the utilization rate of postoperative deep vein thrombosis (DVT) prophylaxis and compare the incidence and severity of bleeding and thrombotic complications in elective spine surgery patients.
We utilized PearlDiver, a national orthopedics claims database. All patients who underwent elective spine surgery from 2007 to 2017 were included. Patients were stratified by the presence of DVT prophylaxis drug codes, then by comorbidities for postoperative bleeding/thrombosis. The severity of all bleeding and thrombotic complications in each cohort was studied, including the incidence of complications requiring operative washout, diagnosis of pulmonary embolism, intensive care unit admission, and mortality.
A total of 119 888 patients were included. The majority of patients (118 720, >99%) were not administered postoperative DVT chemoprophylaxis while a minority of patients (1168) were. The overall rates of bleeding and thrombotic complications within the population not receiving DVT prophylaxis were 1.96% and 2.45%, respectively ( < .001). The incidence of surgical intervention for a wound washout was 0.62% compared with 1.05% for pulmonary embolism ( < .001). Intensive care unit admission rates related to a wound washout procedure or pulmonary embolism also significantly differed (0.07% vs 0.34%, < .001). There were no observed differences in mortality. When controlling for patient comorbidity, patients with atrial fibrillation, cancer, or a prior history of thrombotic complications experienced the greatest increased risks of postoperative thrombosis.
DVT prophylaxis is not routinely utilized following elective spine procedures. We report that there exist specific populations which may receive benefit from these practices, although further study is necessary to determine optimal prevention strategies for both thrombotic and bleeding complications in spine surgery.
回顾性数据库分析。
研究择期脊柱手术患者术后深静脉血栓形成(DVT)预防措施的使用率,并比较出血和血栓形成并发症的发生率及严重程度。
我们使用了PearlDiver,一个全国性的骨科索赔数据库。纳入了2007年至2017年期间接受择期脊柱手术的所有患者。根据是否存在DVT预防药物代码对患者进行分层,然后根据术后出血/血栓形成的合并症进行分层。研究了每个队列中所有出血和血栓形成并发症的严重程度,包括需要手术冲洗的并发症发生率、肺栓塞诊断、重症监护病房入住率和死亡率。
共纳入119888例患者。大多数患者(118720例,>99%)未接受术后DVT化学预防,少数患者(1168例)接受了预防。未接受DVT预防的人群中出血和血栓形成并发症的总体发生率分别为1.96%和2.45%(P<0.001)。伤口冲洗的手术干预发生率为0.62%,而肺栓塞的发生率为1.05%(P<0.001)。与伤口冲洗手术或肺栓塞相关的重症监护病房入住率也有显著差异(0.07%对0.34%,P<0.001)。未观察到死亡率的差异。在控制患者合并症时,房颤、癌症或有血栓形成并发症既往史的患者术后血栓形成风险增加最大。
择期脊柱手术后并非常规使用DVT预防措施。我们报告称,存在特定人群可能从这些措施中获益,尽管需要进一步研究以确定脊柱手术中血栓形成和出血并发症的最佳预防策略。